Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma

BACKGROUND: Liver cancer is the fifth most common cancer and the second cause of cancer-related deaths worldwide. Transarterial chemoembolization (TACE) is the best treatment of intermediate hepatocellular carcinoma (HCC). Doxorubicin is the most commonly used drug despite a low level of evidence. A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Roth, Gaël Stéphane, Teyssier, Yann, Abousalihac, Mélodie, Seigneurin, Arnaud, Ghelfi, Julien, Sengel, Christian, Decaens, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2020
Assuntos:
Retrospective Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6969879/
https://ncbi.nlm.nih.gov/pubmed/31988592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i3.324
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados